Beneficial effect of multiple drug therapy including tacrolimus in clinical renal transplantation.
Okamoto
M
M
Second Department of Surgery and Department of Hospital Pharmacy, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Yoshimura
N
N
Nakai
I
I
Nakajima
H
H
Ushigome
H
H
Sakaguchi
K
K
Ohmori
Y
Y
Yoshimura
R
R
Sugioka
N
N
Oka
T
T
D000293:Adolescent; D000328:Adult; D019540:Area Under Curve; D001379:Azathioprine / Q000627:therapeutic use; D002648:Child; D003404:Creatinine / Q000097:blood; D004359:Drug Therapy, Combination; D005260:Female; D006084:Graft Rejection / Q000517:prevention & control; D006207:Half-Life; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D008297:Male; D008875:Middle Aged; D012263:Ribonucleosides / Q000627:therapeutic use; D016559:Tacrolimus / Q000009:adverse effects / Q000493:pharmacokinetics* / Q000627:therapeutic use*
D007166:Immunosuppressive Agents; D012263:Ribonucleosides; C010052:mizoribine; D003404:Creatinine; D001379:Azathioprine; D016559:Tacrolimus